We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Combines MRI with Pathology and Genetic Data to Better Detect Aggressive Prostate Cancer

By MedImaging International staff writers
Posted on 25 Dec 2023
Print article
Image: Researchers are using multi-modal modeling approach to detect aggressive prostate cancer (Photo courtesy of UCLA Health)
Image: Researchers are using multi-modal modeling approach to detect aggressive prostate cancer (Photo courtesy of UCLA Health)

Prostate cancer continues to pose a significant health challenge for men, despite medical advancements. The prevalent screening and risk assessment techniques often result in excessive diagnosis and treatment. Remarkably, while 90% of diagnosed individuals undergo treatment, up to 60% might be better suited for active surveillance instead Now, a team of researchers is exploring innovative methods to more accurately detect prostate cancer and assess its aggression through medical imaging, histology, genetic data, and other risk indicators. The goal is to minimize overdiagnosis and overtreatment, thereby sparing patients from unnecessary interventions and their consequent adverse effects.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center (Los Angeles, CA, USA) have received a five-year, USD 3 million grant from the National Cancer Institute to discover new cancer biomarkers and create artificial intelligence (AI) capable of identifying and predicting the aggressiveness of prostate cancer. This research aims to avoid unnecessary treatments and their detrimental side effects for patients. By integrating data from magnetic resonance imaging, digital histology images, genetic profiles, and biomarkers into a comprehensive computational model, the researchers aim to accurately capture a patient's current cancer status and predict future outcomes.

“We expect this approach to be able to provide more accurate information about the nature of the cancer, helping doctors to distinguish between aggressive and less threatening forms,” said Dr. Corey Arnold, director of the UCLA Computational Diagnostics team. “It will also allow for more personalized and targeted treatment plans, reducing unnecessary interventions and their associated negative effects on patients’ quality of life.”

Related Links:
UCLA Health 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
Brachytherapy Planning System
Oncentra Brachy
Ultrasound Doppler System
Doppler BT-200

Print article

Channels

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.